Digoxin and Senolysis in Heart Failure and Diabetes Mellitus
Conditions: Heart Failure, Systolic; Diabetes Mellitus, Type 2 Interventions: Drug: Digoxin 0.125 MG Sponsors: University of Leeds Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy
Conditions: Conduction System Pacing; Biventricular Pacing; Cardiac Resynchronization Therapy; Right Ventricular Pacing; Heart Failure Interventions: Device: Conduction system pacing; Device: Biventricular pacing Sponsors: The First Affiliated Hospital with Nanjing Medical University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; The First Affiliated Hospital of Soochow University; The Affiliated Hospital of Xuzhou Medical University; The Affiliated Changzhou Second People ' s Hospital of Nanjing Medical University; The Third Affiliated Hospital of Soochow University; The Affiliated Zhangjiagang Hospital of Sooc...
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Telemedicine in Heart Failure; Treatment, Prognosis and Patient Experience
Conditions: Heart Failure Interventions: Device: Telemedicine Sponsors: Sahlgrenska University Hospital, Sweden; Skaraborgs Hospital; Southern Älvsborg Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
A Trial to Learn How REGN5381 Works and How Safe it is in Adults With Heart Failure With Reduced Ejection Fraction (HFrEF)
Conditions: Heart Failure Interventions: Drug: REGN5381; Drug: Placebo Sponsors: Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
The Gender-Based Differences in the Outcome of Treatment by Aldosterone Antagonists in Patients With Heart Failure
Conditions: Heart Failure; Heart Failure With Reduced Ejection Fraction; Heart Failure NYHA Class II; Heart Failure NYHA Class III; Heart Failure NYHA Class IV Interventions: Drug: Potassium sparing diuretic Sponsors: Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
Conditions: Advanced Heart Failure; Advanced Non-colorectal Gastro-intestinal Cancer; Advanced Lung Cancer Interventions: Behavioral: Tier - Palliative Care Sponsors: Icahn School of Medicine at Mount Sinai; National Institute of Nursing Research (NINR) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Clinical Characteristics and Predictors of Adverse Outcomes in HFpEF
Conditions: Heart Failure With Preserved Ejection Fraction Interventions: Combination Product: The study involved a comparison of clinical characteristics, medical history, laboratory biomarkers, echocardiographic measurements, angiographic findings, and clinical outcomes between two groups. Sponsors: Ya-Wei Xu Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
BVA-200 vs BVA-100 Validation Study
Conditions: Heart Failure; High Blood Pressure; High Cholesterol; Anemia; Diabetes; Thyroid Diseases; Kidney Diseases; Clotting Disorder; Trauma; Other Disease Interventions: Diagnostic Test: BVA-200 Sponsors: Daxor Corporation; Stern Cardiovascular Foundation, Inc.; Oregon Health and Science University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Ketones, SGLT2, HFrEF
Conditions: Type2diabetes; Heart Failure With Reduced Ejection Fraction Interventions: Drug: Empagliflozin 25 MG Oral Tablet; Drug: Placebo; Drug: Acipimox 250 Mg Oral Capsule Sponsors: The University of Texas Health Science Center at San Antonio; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Effect of Personalized Follow-up in Adapted Physical Activities in Subjects With Chronic Heart Failure.
Conditions: Heart Failure Interventions: Other: Experimental arm Sponsors: University Hospital, Brest Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
The HEARTFELT Study
Conditions: Heart Failure Interventions: Device: Heartfelt Device installed; Other: Standard care; Device: Direct-to-patient alerts; Device: RPMC care; Other: Questionnaires Sponsors: Heartfelt Technologies Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
Conditions: Heart Failure, Congestive Interventions: Drug: Furosemide; Drug: Torsemide; Drug: Bumetanide; Drug: sacubitril/valsartan; Drug: Hydralazine; Drug: Isosorbide Dinitrate Sponsors: Heart Center Research, LLC; Boston Scientific Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)
Conditions: Heart Failure; Heart Failure Preserved Ejection Fraction; Cardiovascular Diseases; Heart Diseases Interventions: Drug: Tovinontrine (CRD-750; Drug: Placebo Sponsors: Cardurion Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure With Preserved Ejection Fraction; Microvascular Coronary Artery Disease Interventions: Drug: Colchicine 0.5 MG Sponsors: Montreal Heart Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Myocardial Dysfunction Evaluation in Lower Extremity Arterial Disease Patients With Deformation Analysis
Conditions: Peripheral Artery Disease; Heart Failure Sponsors: Tartu University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
